Teva Pharma AG
Teva Pharma AG is a Generics company based in Basel (Basel-Stadt) recorded by Swissmedic as the authorisation holder for 68 human medicines. That places it 18 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Synthetika.
Key facts
| Sector | Generics |
|---|---|
| City | Basel |
| Canton | Basel-Stadt |
| Authorisation holder | Yes |
| Medicines | 68 |
| Founded | Not available |
| Employees | 11-50 |
| Parent group | Teva Pharmaceutical Industries |
| Activity | Not available |
| Website | Not available |
Medicines authorised in Switzerland
Teva Pharma AG is recorded by Swissmedic as the authorisation holder for 68 human medicines. The table shows 48 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
48 of 68 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| AJOVY 225 mg | 67284 | B | N02CD03 | 2019-12-06 |
| AJOVY 225 mg | 67843 | B | N02CD03 | 2020-07-31 |
| Anastrozol-Teva | 58794 | B | L02BG03 | 2009-01-29 |
| Antabus 400 mg | 15104 | B | N07BB01 | 1949-12-01 |
| Azilect | 57065 | B | N04BD02 | 2005-12-20 |
| Bevacizumab-Teva 100 mg/4 ml | 67886 | A | L01FG01 | 2021-05-10 |
| Bicalutamid-Teva 50 mg | 58427 | B | L02BB03 | 2009-05-14 |
| Bosutinib-Teva 100 mg | 69223 | A | L01EA04 | 2024-05-28 |
| Cabazitaxel-Teva 60 mg/6 ml | 68597 | A | L01CD04 | 2022-10-11 |
| Capecitabin-Teva 150 mg | 62822 | A | L01BC06 | 2013-01-30 |
| Carboplatin-Teva liquid 50 mg / 5 ml | 58289 | A | L01XA02 | 2008-02-27 |
| Cedur retard | 45352 | B | C10AB02 | 1983-04-22 |
| Cinqaero 100 mg/10 mL | 66340 | B | R03DX08 | 2017-11-09 |
| Colistin zur Infusion 1 Mio IE | 67406 | A | J01XB01 | 2020-05-12 |
| Colistin zur Inhalation 1 Mio U.I. | 54915 | A | J01XB01 | 2000-04-26 |
| Copaxone 20mg/ml | 56363 | B | L03AX13 | 2004-01-22 |
| Copaxone Pen 40 mg/ml | 67492 | B | L03AX13 | 2024-05-16 |
| Dasatinib-Teva 20 mg | 67100 | A | L01EA02 | 2019-05-03 |
| Denosumab-Teva onco 120 mg / 1.7 ml | 70132 | A | M05BX04 | 2025-12-10 |
| Dobutrex 250 mg/50 ml | 45687 | B | C01CA07 | 1988-04-29 |
| Docetaxel-Teva liquid 20 mg/1 ml | 60726 | A | L01CD02 | 2011-01-21 |
| Donepezil-Teva Medika 5 mg | 62103 | B | - | 2011-08-18 |
| Doxorubicin-Teva 10 mg/5 ml | 59350 | A | L01DB01 | 2009-12-02 |
| DuoResp Spiromax 160 ug / 4.5 ug | 70193 | B | R03AK07 | 2026-04-02 |
| Epirubicin-Teva 10 mg/5 ml | 58676 | A | - | 2008-11-14 |
| Epirubicin-Teva liquid 10 mg/5 ml | 58274 | A | L01DB03 | 2008-01-28 |
| EpoTheta-Teva 1000 | 59636 | A | B03XA01 | 2010-11-24 |
| Filgrastim-Teva 30 / 0.5 ml | 60722 | A | L03AA02 | 2010-01-08 |
| Finasterid-Teva 5 mg | 58339 | B | - | 2008-09-19 |
| Floxapen 500 mg i.v./i.m. | 37404 | B | J01CF05 | 1972-11-16 |
| Fludarabin-Teva | 58535 | A | L01BB05 | 2008-06-20 |
| Fluorouracil-Teva | 47160 | A | L01BC02 | 1986-01-31 |
| Fulvestrant-Teva 250mg/5ml | 66470 | B | L02BA03 | 2017-07-27 |
| Gemcitabin-Teva liquid 200 mg / 5 ml | 65005 | A | L01BC05 | 2014-04-08 |
| Imatinib GIST-Teva 100 mg | 66621 | A | L01EA01 | 2017-07-10 |
| Imatinib-Teva 100 mg | 65155 | A | L01EA01 | 2014-05-01 |
| Ipramol Steri-Nebs | 58253 | B | R03AL02 | 2008-06-03 |
| Irinotecan-Teva liquid 40 mg/2 ml | 59217 | A | L01CE02 | 2009-05-06 |
| Kefzol 1 g | 38210 | A | J01DB04 | 1974-02-19 |
| Kentera | 57733 | B | G04BD04 | 2007-04-23 |
| Lenalidomid-Teva 2.5 mg | 67460 | A | L04AX04 | 2019-11-05 |
| Lenvatinib-Teva 4 mg | 70497 | A | L01EX08 | 2026-03-23 |
| Letrozol-Teva 2 | 60394 | B | L02BG04 | 2011-03-28 |
| Leucovorin-Teva 50 mg / 5 ml | 58499 | B | V03AF03 | 2009-01-21 |
| Methotrexat Teva Onco 50 mg/2 ml | 47999 | A | L01BA01 | 1987-10-23 |
| Myfenax 250 mg | 59220 | B | L04AA06 | 2009-06-17 |
| Myfenax 500 mg | 59221 | B | L04AA06 | 2009-06-17 |
| Neotigason 10 mg | 49227 | A | D05BB02 | 1990-03-19 |
Frequently asked questions
How many medicines does Teva Pharma AG have authorised in Switzerland?
Teva Pharma AG is recorded by Swissmedic as the authorisation holder for 68 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Teva Pharma AG based?
The Swiss location recorded for Teva Pharma AG is Basel, Basel-Stadt.
Is Teva Pharma AG a Swissmedic authorisation holder?
Yes. Teva Pharma AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.